Overview

A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP)

Status:
Completed

Trial end date:
2016-09-22

Target enrollment:

Participant gender:

Summary

This was a randomized, multicenter, multinational, double-blind study comparing the efficacy and safety of plazomicin compared with meropenem followed by optional oral (PO) therapy in the treatment of cUTI, including AP, in adults.

Phase:

Phase 3

Details

Lead Sponsor:

Achaogen, Inc.

Treatments:

Levofloxacin
Meropenem
Ofloxacin
Thienamycins